Scientists reprogram immune cells inside the body to fight cancer
Scientists at UC San Francisco have developed a method to reprogram immune cells inside the body to fight cancer, using CRISPR technology. This approach could make CAR-T therapy faster, cheaper, and more accessible by avoiding the current complex and expensive process of modifying cells outside the body. The technique successfully targeted cancer in mice and may lead to broader applications in cell and gene therapies.
Researchers used a CRISPR-based method to insert cancer-targeting DNA directly into T cells inside the body, creating cancer-fighting cells without removing them first. This technique was tested in mice and showed promise against different types of cancer.
This development could significantly reduce the cost and time needed for CAR-T therapy, making it more widely available to patients. It also offers a more precise way to edit genes, which could improve the effectiveness and safety of future treatments.
The breakthrough shows how scientific innovation can simplify complex medical treatments, offering hope for more accessible and effective cancer care. It highlights the potential for new therapies that can reach more people in need.
upbeatBytes summarizes in its own words and links to the original publisher — it doesn't host the article.